UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000021910 |
|---|---|
| Receipt number | R000025272 |
| Scientific Title | The opportune time for periarticular injection during total knee arthroplasty under general anesthesia: a randomized controlled trial |
| Date of disclosure of the study information | 2016/04/14 |
| Last modified on | 2018/09/21 08:12:18 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The opportune time for periarticular injection during total knee arthroplasty under general anesthesia: a randomized controlled trial
Acronym
The opportune time for periarticular injection during total knee arthroplasty under general anesthesia: a randomized controlled trial
Scientific Title
The opportune time for periarticular injection during total knee arthroplasty under general anesthesia: a randomized controlled trial
Scientific Title:Acronym
The opportune time for periarticular injection during total knee arthroplasty under general anesthesia: a randomized controlled trial
Region
| Japan |
Condition
Condition
Osteoarthritis of the knee, rheumatoid arthritis, avascular necrosis
Classification by specialty
| Orthopedics | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The aim of this study is to compare the efficacy of periarticular injection between the superficial injection after the implantation of prosthesis and the superficial injection just prior to the arthrotomy in total knee arthroplasty under general anesthesia.
In the both groups, the deep injection is performed just prior to the implantation of prosthesis.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Pain score (Visual analogue scale) at recovery room
Key secondary outcomes
Pain score (Visual analogue scale) 3 and 6 hours after surgery and 1 day after surgery
Blood loss
Complications
The consumption of remifentanil
The use of naloxone
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Single blind -participants are blinded
Control
Active
Stratification
NO
Dynamic allocation
NO
Institution consideration
Blocking
NO
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Medicine | Maneuver |
Interventions/Control_1
Superficial injection after the implantation of prosthesis
Interventions/Control_2
Superficial injection just prior to the arthrotomy
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients scheduled for unilateral total knee arthroplasty
Key exclusion criteria
Patients scheduled for simultaneous bilateral total knee arthroplasty.
Patients who had allergy or intolerance to one of the study drugs, regular narcotic use, renal insufficiency and prolonged QT interval on ECG.
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Sachiyuki Tsukada |
Organization
Hokusuikai Kinen Hospital
Division name
Orthopaedic surgery
Zip code
Address
3-2-1 Higashihara, Mito, Ibaraki, 310-0035 Japan
TEL
029-303-3003
s8058@nms.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Sachiyuki Tsukada |
Organization
Hokusuikai kinen hospital
Division name
Orthopaedic surgery
Zip code
Address
3-2-1 Higashihara, Mito, Ibaraki, 310-0035 Japan
TEL
029-303-3003
Homepage URL
s8058@nms.ac.jp
Sponsor or person
Institute
Hokusuikai Kinen Hospital
Institute
Department
Personal name
Funding Source
Organization
Hokusuikai Kinen Hospital
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 04 | Month | 14 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
https://link.springer.com/article/10.1007%2Fs00167-018-5140-y
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2016 | Year | 02 | Month | 17 | Day |
Date of IRB
Anticipated trial start date
| 2016 | Year | 09 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2016 | Year | 04 | Month | 14 | Day |
Last modified on
| 2018 | Year | 09 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025272
